3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Polycystic Ovary Syndrome
4
Inflammation
2
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Skin Diseases
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Rare Diseases
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Migraine Disorders
1
Metabolic Syndrome
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Influenza, Human
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperandrogenism
1
Hyperaldosteronism
1
Interventions
Therapeutics
9
Psychiatric Rehabilitation
9
Music Therapy
8
Cognitive Behavioral Therapy
7
Mindfulness
6
Surveys and Questionnaires
5
Counseling
5
Acupuncture Therapy
5
Standard of Care
4
Mindfulness-Based Stress Reduction
4
Methods
4
Imagery, Psychotherapy
4
Early Intervention, Educational
4
Autogenic Training
4
Art Therapy
4
Therapeutic Touch
3
Psychosocial Intervention
3
Psilocybin
3
Mindfulness-Based Cognitive Therapy
3
Massage
3
Hypnosis
3
Exercise
3
Control Groups
3
Aromatherapy
3
Acceptance and Commitment Therapy
3
Yoga
2
Touch
2
Observation
2
Niacin
2
Gabapentin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anxiety Disorders
×
Spironolactone
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled